TrHLINE 2.0 %

Intra-articular injection of linear hyaluronic acid.

Restores the viscoelastic properties of synovial fluid, relieving pain and increasing mobility.

Concentration: 20 mg/mL
Presentation: 2 mL disposable, non-pyrogenic, sterile prefilled syringe with Luer lock
Certification: Class III Medical Device (MDR)
Recommended needle: 21 - 23G
Shelf life: 2 years
Technology: Linear sodium hyaluronate hydrogel.

Degradación Lenta

Visco-Elástico

Buen perfil de seguridad

Alta biocompatibilidad

Elasticidad y resistencia

Biocompatibles

Advantages

Manufactured in Europe under rigorous quality standards.
Low endotoxin level ≤ 0.20 EU/mL.
Intra-articular durability of 6 months.
Medium viscosity, designed for optimal handling.
Contributes to symptomatic improvement in patients.
Supports the recovery of joint function.

Indications

Indicated for viscosupplementation of knee synovial fluid with linear HA when its viscosity has decreased due to osteoarthritis.

Properties

Provides a cushioning and lubricating effect.
Reduces pain and improves the functionality of the affected joint.

Directions for use

For intra-articular administration only by healthcare professionals specialising in traumatology, in accordance with all rules governing aseptic procedure and injection technique to ensure treatment safety and efficacy. The recommended dose of TrHLINE 2.0% is one complete injection per treatment session, with a total of 3 injections administered at weekly intervals.

Technology

Linear sodium hyaluronate hydrogel.